Kadant (NYSE:KAI - Get Free Report) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a report released on Thursday.
A number of other equities analysts have also recently issued reports on the company. DA Davidson dropped their price objective on Kadant from $300.00 to $275.00 and set a "neutral" rating for the company in a report on Thursday, May 1st. Barrington Research reaffirmed an "outperform" rating and issued a $380.00 price target on shares of Kadant in a research note on Thursday, May 1st.
Get Our Latest Analysis on KAI
Kadant Trading Down 0.2%
Shares of Kadant stock traded down $0.61 during trading on Thursday, hitting $306.40. The stock had a trading volume of 27,451 shares, compared to its average volume of 111,446. Kadant has a 12 month low of $266.23 and a 12 month high of $429.95. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.29 and a quick ratio of 1.46. The firm's fifty day simple moving average is $317.94 and its 200-day simple moving average is $355.20. The stock has a market cap of $3.61 billion, a PE ratio of 32.27 and a beta of 1.30.
Kadant (NYSE:KAI - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The industrial products company reported $2.10 earnings per share for the quarter, topping analysts' consensus estimates of $1.97 by $0.13. Kadant had a net margin of 10.59% and a return on equity of 14.66%. The company had revenue of $239.21 million for the quarter, compared to analyst estimates of $239.41 million. During the same period in the prior year, the company posted $2.38 EPS. The firm's revenue for the quarter was down 3.9% on a year-over-year basis. As a group, sell-side analysts expect that Kadant will post 9.97 EPS for the current fiscal year.
Kadant announced that its board has authorized a share buyback program on Thursday, May 15th that allows the company to repurchase $50.00 million in shares. This repurchase authorization allows the industrial products company to buy up to 1.3% of its shares through open market purchases. Shares repurchase programs are often a sign that the company's board of directors believes its shares are undervalued.
Institutional Investors Weigh In On Kadant
A number of large investors have recently modified their holdings of KAI. Synovus Financial Corp boosted its stake in Kadant by 1.7% in the 4th quarter. Synovus Financial Corp now owns 1,761 shares of the industrial products company's stock worth $608,000 after purchasing an additional 29 shares in the last quarter. Bank of Montreal Can grew its holdings in shares of Kadant by 3.2% during the fourth quarter. Bank of Montreal Can now owns 1,187 shares of the industrial products company's stock valued at $410,000 after buying an additional 37 shares during the last quarter. Apollon Wealth Management LLC increased its position in shares of Kadant by 2.2% in the 1st quarter. Apollon Wealth Management LLC now owns 1,795 shares of the industrial products company's stock valued at $605,000 after acquiring an additional 39 shares during the period. Cetera Investment Advisers raised its stake in Kadant by 5.6% in the 1st quarter. Cetera Investment Advisers now owns 760 shares of the industrial products company's stock worth $256,000 after acquiring an additional 40 shares during the last quarter. Finally, Xponance Inc. raised its stake in Kadant by 5.1% in the 1st quarter. Xponance Inc. now owns 888 shares of the industrial products company's stock worth $299,000 after acquiring an additional 43 shares during the last quarter. Hedge funds and other institutional investors own 96.13% of the company's stock.
About Kadant
(
Get Free Report)
Kadant Inc supplies technologies and engineered systems worldwide. It operates in three segments: Flow Control, Industrial Processing, and Material Handling. The Flow Control segment develops, manufactures, and markets fluid-handling systems and equipment, such as rotary joints, syphons, turbulator bars, expansion joints, and engineered steam and condensate systems; and doctoring, cleaning, and filtration systems and related consumables consisting of doctor systems and holders, doctor blades, cleaning shower and fabric-conditioning systems, forming systems and wear surfaces, and water-filtration systems.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kadant, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kadant wasn't on the list.
While Kadant currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.